Last updated on October 2020

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Patients With Asthma


Brief description of study

The primary objective of the study is to demonstrate that dupilumab treatment improves exercise capacity in patients with moderate-to-severe asthma.

The secondary objectives of the study are:

  • To demonstrate that dupilumab treatment increases physical activity of daily living in patients with moderate-to-severe asthma
  • To demonstrate that dupilumab treatment improves pre- and post-exercise lung function in patients with moderate-to-severe asthma

Clinical Study Identifier: NCT04203797

Find a site near you

Start Over

Regeneron Research Site

Charlotte, NC United States
  Connect »

Regeneron Study Site

Rolling Hills Estates, CA United States
  Connect »

Regeneron Study Site

Westminster, CA United States
  Connect »

Regeneron Study Site

North Dartmouth, MA United States
  Connect »

Regeneron Study Site

Charlotte, NC United States
  Connect »

Regeneron Study Site

Cleveland, OH United States
  Connect »

Regeneron Study Site

Frankfurt am Main, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.